Logo
x

Search category

Subscribe Now

(pirfenidone)

Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD

Roche Reports the US FDA's Acceptance of sNDA and Granted Priority Review for Esbriet (pirfenidone) to Treat UILD

  • January 21, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.